INDUCTION OF INFLAMMATORY CYTOKINE RELEASE FROM HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS BY AGONISTS OF PROTEINASE-ACTIVATED RECEPTOR-2

Authors

  • Qing-Xia Niu,

    1. Allergy and Inflammation Research Institute, Key Immunopharmacology Laboratory of Guangdong Province, Shantou University Medical College,
    Search for more papers by this author
  • Han-Qiu Chen,

    1. Allergy and Inflammation Research Institute, Key Immunopharmacology Laboratory of Guangdong Province, Shantou University Medical College,
    Search for more papers by this author
  • Zhuo-Yi Chen,

    1. Department of Anaesthesiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong and
    Search for more papers by this author
  • Yi-Ling Fu,

    1. Allergy and Inflammation Research Institute, Key Immunopharmacology Laboratory of Guangdong Province, Shantou University Medical College,
    Search for more papers by this author
  • Jie-Lian Lin,

    1. Allergy and Inflammation Research Institute, Key Immunopharmacology Laboratory of Guangdong Province, Shantou University Medical College,
    Search for more papers by this author
  • Shao-Heng He

    1. Allergy and Inflammation Research Institute, Key Immunopharmacology Laboratory of Guangdong Province, Shantou University Medical College,
    2. Clinical Research Centre, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
    Search for more papers by this author

Professor Shao-Heng He, Allergy and Inflammation Research Institute, Shantou University Medical College, 22 Xin-Ling Road, Shantou 515041, China. Email: shoahenghe@hotmail.com

SUMMARY

  • 1Human endothelial cells express proteinase-activated receptor-2 (PAR-2), inflammatory cytokines and trypsin (EC 3.4.21.4). However, little is known about the mechanism through which trypsin induces cytokine release from endothelial cells.
  • 2In the present study, we investigated the effect of trypsin on cytokine release from primary cultures of human umbilical vein endothelial cells (HUVEC) using an antibody based protein microarray and ELISA.
  • 3The results showed that 1 mg/mL trypsin induced release of 32 different inflammatory factors, whereas 100 mmol/L Ser-Leu-Ile-Gly-Lys-Val-NH2 (SLIGKV-NH2) only stimulated secretion of 16 inflammatory factors from HUVEC, as assessed by an antibody based protein microarray. Because the release of interleukin (IL)-1a, IL-8, IL-10 and IL-12 was markedly increased following PAR-2 activation, their release was investigated further using ELISA. Increases in release of up to approximately 4.8-, 4.3-, 4.1- and 1.8-fold were observed for IL-1a, IL-10, IL-12 and IL-8, respectively, when HUVEC were challenged with trypsin for 16 h. Agonist peptides of PAR-2, namely SLIGKV-NH2 and trans-cinnamoyl-Leu-Ile-Gly-Arg-Leu-Orn-NH2 (tc-LIGRLO-NH2), also provoked significant release of IL-8. Trypsin-induced cytokine release was inhibited by its inhibitors soybean trypsin inhibitor, a1-antitrypsin and the inhibitor peptide of PAR-2 Phe-Ser-Leu-Leu-Arg-Tyr-NH2 (FSLLRY-NH2).
  • 4These data indicate the action of trypsin on HUVEC is most likely through activation of PAR-2, suggesting that PAR-2-related mechanisms are involved in the inflammatory process in humans.

Ancillary